Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis-Reference-Cited by-同舟云学术

Inhibition of activator protein 1 signaling abrogates transforming growth factor β-mediated activation of fibroblasts and prevents experimental fibrosis

Published:2012-04-26 Issue:5 Volume:64 Page:1642-1652
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Avouac Jérôme,Palumbo Katrin,Tomcik Michal,Zerr Pawel,Dees Clara,Horn Angelika,Maurer Britta,Akhmetshina Alfiya,Beyer Christian,Sadowski Anika,Schneider Holm,Shiozawa Shunichi,Distler Oliver,Schett Georg,Allanore Yannick,Distler Jörg H. W.

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.33501/fullpdf

Reference32 articles.

1. Scleroderma;Gabrielli;N Engl J Med,2009

2. New therapeutic strategies in the management of systemic sclerosis;Allanore;Expert Opin Pharmacother,2007

3. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database;Tyndall;Ann Rheum Dis,2010

4. Fibrosis in systemic sclerosis;Varga;Rheum Dis Clin North Am,2008

5. Transforming growth factor β as a therapeutic target in systemic sclerosis;Varga;Nat Rev Rheumatol,2009

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Jun and JunB members of the AP-1 complex are potential therapeutic targets for silicosis;International Journal of Biological Macromolecules;2024-10

2. Identification of key genes as potential diagnostic and therapeutic targets for comorbidity of myasthenia gravis and COVID-19;Frontiers in Neurology;2024-02-07

3. Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases;Current Medicinal Chemistry;2024-02

4. Overview of Animal Models;Scleroderma;2024

5. c‐FOS is an integral component of the IKZF1 transactivator complex and mediates lenalidomide resistance in multiple myeloma;Clinical and Translational Medicine;2023-08